본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea v.33 no.6, 2010년, pp.925 - 932   SCIE 피인용횟수: 2
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Resveratrol Inhibits Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats

Lee, Eun-Sil    (College of Pharmacy, Pusan National University   ); Shin, Mi-Ok    (College of Pharmacy, Pusan National University   ); Yoon, Sik    (Department of Anatomy, College of Medicine, Pusan National University   ); Moon, Jeon-Ok    (College of Pharmacy, Pusan National University  );
  • 초록

    Resveratrol, a phytoalexin found in grapes and red wines, has been reported to exhibit a wide range of pharmacological properties. In this study, we investigated the protective effect of resveratrol on hepatic injury induced by dimethylnitrosamine (DMN) in rats. Oral administration of resveratrol (20 mg/kg daily for 4 weeks) remarkably prevented the DMN-induced loss in body and liver weight, and inhibited the elevation of serum alanine transaminase, aspartate transaminase, alkaline phosphatase and bilirubin levels. Resveratrol also increased serum albumin and hepatic glutathione levels and reduced the hepatic level of malondialdehyde due to its antioxidant effect. Furthermore, DMN-induced elevation of hydroxyproline content was reduced in the resveratrol treated rats, the result of which was consistent with the reduction in type I collagen mRNA expression and the histological analysis of liver tissue stained with Sirius red. The reduction in hepatic stellate cell activation, as assessed by ${\alpha}$ -smooth muscle actin staining, and the reduction in transforming growth factor- ${\beta}1$ mRNA expression were associated with resveratrol treatment. In conclusion, resveratrol exhibited in vivo hepatoprotective and antifibrogenic effects against DMN-induced liver injury, suggesting that resveratrol may be useful in the prevention of the development of hepatic fibrosis.


  • 주제어

    Resveratrol .   Hepatoprotective effect .   Antifibrogenic effect .   Antioxidant effect .   Hepatic stellate cell .   TGF- ${\beta}1$.  

  • 참고문헌 (29)

    1. Ara, C., Kirimlioglu, H., Karabulut, A. B., Coban, S., Ay, S., Harputluoglu, M., and Yilmaz, S., Protective effect of resveratrol against oxidative stress in cholestasis. J. Surg. Res., 127, 112-117 (2005). 
    2. Bataller, R. and Brenner, D. A., Liver fibrosis. J. Clin. Invest., 115, 209-218 (2005). 
    3. Buege, J. A. and Aust, S. D., Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310 (1978). 
    4. Chavez, E., Reyes-Gordillo, K., Segovia, J., Shibayama, M., Tsutsumi, V., Vergara, P., Moreno, M. G., and Muriel, P., Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J. Appl. Toxicol., 28, 35-43 (2008). 
    5. Friedman, S. L., Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669 (2008a). 
    6. Friedman, S. L., Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev., 88, 125-172 (2008b) 
    7. Gasso, M., Rubio, M., Varela, G., Cabre, M., Caballeria, J., Alonso, E., Deulofem, R., Camps, J., Gimene, Z, A., Piares, M., Pares, A., Mato, J. M., and Rodes, J., Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J. Hepatol., 25, 200-205 (1996). 
    8. Godichaud, S., Krisa, S., Couronne, B., Dubuisson, L., Merillon, J.-M., Desmouliere, A., and Rosenbaum, J., Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology, 31, 922-931 (2000). 
    9. Godichaud, S., Si-Tayeb, K., Auge, N,. Desmouliere, A., Balabaud, C., Payrastre, B., Negre-Salvayre, A., and Rosenbaum, J., The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. Int. J. Biochem. Cell Biol., 38, 629-637 (2006). 
    10. Haggerty, H. G. and Holsapple, M. P., Role of metabolism in dimethylnitrosamine-induced immunosuppression: A review. Toxicology, 63, 1-23 (1990). 
    11. Junqueira, L. C., Bignolas, G., and Brentani, R. R., Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J., 11, 447-455 (1979). 
    12. Kawada, N., Seki, S., Inoue, M., and Kuroki, T., Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 27, 1265-1274 (1998). 
    13. Kolios, G., Valatas. V., and Kouroumalis E., Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol., 14, 7413-7420 (2006). 
    14. Lee, E. S., Lee, H. E., Shin, J. Y., Yoon, S., and Moon, J. O., The flavonoid quercetin inhibits dimethylnitrosamineinduced liver damage in rats. J. Pharm. Pharmcol., 55, 1169-1174 (2003). 
    15. Li, D. and Friedman, S. L., Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol., 14, 618-633 (1999). 
    16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randal, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951). 
    17. Moreira, R. K., Hepatic stellate cells and liver fibrosis. Arch. Pathol. Lab. Med., 131, 1728-1734 (2007). 
    18. Rubiolo, J. A., Mithieux, G., and Vega, F. V., Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol., 591, 66-72 (2008). 
    19. Shankar, S,. Singh, G., and Srivastava, R. K., Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci., 12, 4839-4854 (2007). 
    20. Terracini, B., Magee, P. N., and Barnes, J. M., Hepatic pathology in rats on low dietary levels of dimethylnitrosamine. Br. J. Cancer, 21, 559-565 (1967). 
    21. Tsukamoto, H., Rippe, R., Niemela, O., and Lin, M., Role of oxidative stress in activation of Kupffer cell and Ito cells in liver fibrogenesis. J. Gastroenterol. Hepatol., 10, S50-S53 (1995). 
    22. Vendemiale, G., Grattagliano, I., Caruso, M. L., Serviddio, G., Valentini, A. M., Pirrelli, M., and Altomare, E., Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol. Appl. Pharmacol., 175, 130-139 (2001). 
    23. Wallace, K., Burt, A. D., and Wright, M. C., Liver fibrosis. Biochem. J., 411, 1-18 (2008). 
    24. Zhu, W. and Fung, P. C., The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radic. Biolic. Med., 29, 870-880 (2000). 
    25. Athar, M., Back, J. H., Tang, X., Kim, H. K., Kopelovich, L., Bickers, D. R., and Kim, A. L., Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 224, 274-283 (2007). 
    26. George, J., Roulot, D., Koteliansky, V. E., and Bissell, D. M., In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc. Natl. Acad. Sci. U.S.A., 96, 12719-12724 (1999). 
    27. Jezequel, A. M., Mancini, R., Ranaldesi, M. L., Balllardini, G., Fallani, M., Bianchi, F., and Orlandi, F., Dimethylnitrosamine- induced cirrhosis. Evidence for an immunological mechanism, J. Hepatol., 8, 42-52 (1989). 
    28. Parola, M., Pinzani, M., Casini, A., Albano, E., Poli, G., Gentilini, A., Gentilini, P., and Dianzani, M. U., Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fatstoring cells. Biochem. Biophys. Res. Commun., 194, 1044-1050 (1993). 
    29. Woessner, J. F. Jr., The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys., 93, 440-447 (1961). 
  • 이 논문을 인용한 문헌 (2)

    1. 2010. "" Nutrition research and practice, 4(5): 369~374     
    2. Gao, Xing-Xi ; Shi, Da-Hua ; Chen, Yun-Xi ; Cui, Jiang-Tao ; Wang, Yu-Rong ; Jiang, Chun-Ping ; Wu, Jun-Hua 2012. "The Therapeutic Effects of Tectorigenin on Chemically Induced Liver Fibrosis in Rats and an Associated Metabonomic Investigation" Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, 35(8): 1479~1493     

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기